Clinical trial
Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis
NCT00844727 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- September 30, 2003
- Completion date
- April 30, 2004
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
duodenal polyposis